| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/25/2014 | US20140378917 Transdermal therapeutic system with a low tendency to spontaneously crystallize |
| 12/25/2014 | US20140378547 Antioxidant compositions for treatment of inflammation or oxidative damage |
| 12/25/2014 | US20140378545 Pregabalin gr tablets |
| 12/25/2014 | US20140378518 Lyophilized formulations of bendamustine hydrochloride |
| 12/25/2014 | US20140378517 Formulations of enzalutamide |
| 12/25/2014 | US20140378512 Composition for improving cognition and memory |
| 12/25/2014 | US20140378497 Sublingual and buccal film compositions |
| 12/25/2014 | US20140378490 Formulations of Phenyl Uracil Compounds |
| 12/25/2014 | US20140378465 Method of treating diabetes |
| 12/25/2014 | US20140378454 Novel methods |
| 12/25/2014 | US20140378441 Therapeutic agent for ocular fundus disease |
| 12/25/2014 | US20140378427 Cabazitaxel-platinum nanoparticles and methods of using same |
| 12/25/2014 | US20140378426 Methods and compositions for enhancing visual function |
| 12/25/2014 | US20140378411 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 12/25/2014 | US20140378410 Composition for inhibiting after-cataract and method for preparing same |
| 12/25/2014 | US20140378407 Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| 12/25/2014 | US20140378406 Silver based gels for antimicrobial applications |
| 12/25/2014 | US20140378395 Peptides for the Treatment of Hearing |
| 12/25/2014 | US20140378383 Methods and compositions for delivery of medicaments to the lungs |
| 12/25/2014 | US20140378381 Stabilized glucagon nanoemulsions |
| 12/25/2014 | US20140378370 Low viscosity highly concentrated suspensions |
| 12/25/2014 | US20140377560 Microporous Zirconium Silicate for the Treatment of Hyperkalemia |
| 12/25/2014 | US20140377389 Pomegranate extract for use in treating rhinitis and sinusitis |
| 12/25/2014 | US20140377375 Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 12/25/2014 | US20140377370 Joint pain treatment composition and method of use |
| 12/25/2014 | US20140377366 Biodegradable polymers for delivery of therapeutic agents |
| 12/25/2014 | US20140377365 Sustained-release formulation of rotigotine |
| 12/25/2014 | US20140377363 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment |
| 12/25/2014 | US20140377362 Hemostatic compositions, devices, and methods |
| 12/25/2014 | US20140377361 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
| 12/25/2014 | US20140377360 Composition for controlled release of physiologically active substance |
| 12/25/2014 | US20140377359 Microporous Zirconium Silicate for the Treatment of Hyperkalemia |
| 12/25/2014 | US20140377358 Nanoparticulate formulation comprising a trpa1 antagonist |
| 12/25/2014 | US20140377357 Poloxamer Based Inhalation Composition |
| 12/25/2014 | US20140377356 Inhalation Composition for Treating Respiratory Tract Infections |
| 12/25/2014 | US20140377355 Levofloxacin Inhalation Composition |
| 12/25/2014 | US20140377354 Flavoured clay-based therapeutic composition |
| 12/25/2014 | US20140377353 Pharmaceutical product to induce endogenous exacerbated release of gut hormones pyy and glp1 with therapeutic effect on obesity and type 2 diabetes mellitus |
| 12/25/2014 | US20140377352 Abuse resistant forms of extended release morphine, method of use and method of making |
| 12/25/2014 | US20140377351 Method and composition for enhancing cognition in alzheimer's patients |
| 12/25/2014 | US20140377350 Bilayer tablet formulations of flurbiprofen and glucosamin |
| 12/25/2014 | US20140377349 Controlled release oral dosage form comprising oxycodone |
| 12/25/2014 | US20140377348 Controlled release hydrocodone formulations |
| 12/25/2014 | US20140377347 In-situ multilayered tablet technology |
| 12/25/2014 | US20140377346 Bosentan controlled release oral preparation |
| 12/25/2014 | US20140377345 Controlled release oral pharmaceutical dosage forms comprising mgbg |
| 12/25/2014 | US20140377344 Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same |
| 12/25/2014 | US20140377343 Formulations of flurbiprofen and diacerein |
| 12/25/2014 | US20140377342 Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
| 12/25/2014 | US20140377339 Tusc2 therapies |
| 12/25/2014 | US20140377337 Transdermal application of prostaglandin e1 for the treatment of ocular ischemia |
| 12/25/2014 | US20140377332 Nanoshells on polymers |
| 12/25/2014 | US20140377330 Bioactive Hydrogel |
| 12/25/2014 | US20140377329 Sublingual films |
| 12/25/2014 | US20140377328 Intraoral soluble-type film preparation |
| 12/25/2014 | US20140377327 Extended release drug-delivery contact lenses and methods of making |
| 12/25/2014 | US20140377322 Multi-layered structure for drug reservoir and drug eluting stent including the same |
| 12/25/2014 | US20140377319 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 12/25/2014 | US20140377313 Formulation for Providing an Enteric Coating Material |
| 12/25/2014 | US20140377312 Transmucosal Administration System for a Pharmaceutical Drug |
| 12/25/2014 | US20140377264 Polypeptide Formulation |
| 12/25/2014 | US20140377190 Compositions, methods and systems for respiratory delivery of two or more active agents |
| 12/25/2014 | US20140377189 Pulmonary administration of rotigotine |
| 12/25/2014 | US20140377176 Functionalised silicon nanoparticles |
| 12/25/2014 | US20140377170 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| 12/25/2014 | US20140377168 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 12/25/2014 | US20140374516 Drug/carrier inclusion composites prepared by a mechanochemical activation process using high-energy fluid-jet mills |
| 12/24/2014 | CN204033821U 一种眼贴 An ophthalmic stickers |
| 12/24/2014 | CN204033820U 折叠贴剂 Folding patch |
| 12/24/2014 | CN204033819U 可重复揭贴且可重复涂布药物的贴膏 Repeatable and reusable stickers expose drug coated Plaster |
| 12/24/2014 | CN204033818U 一种治疗肾病的胶囊 A capsule in the treatment of kidney disease |
| 12/24/2014 | CN204033817U 一种预混合型中药水蜜丸剂 A ready-mixed type of medicine water pill agent |
| 12/24/2014 | CN204033789U 一种纳米药粒的封装设备及外覆包覆膜的纳米药粒 A nano-encapsulated drug particles covered with a coating film equipment and nano-medicine tablets |
| 12/24/2014 | CN104245794A α-氨基脒聚合物及其用途 α- amino amidine polymers and their use |
| 12/24/2014 | CN104244990A 特别用于治疗人体或动物体之手术方法的有色溶液 Colored solutions are particularly useful in the treatment method of surgery of the human or animal body |
| 12/24/2014 | CN104244987A 新型寡核苷酸缀合物及其应用 The new oligonucleotide conjugates and its application |
| 12/24/2014 | CN104244985A 生物材料的稳定化组合物 Stabilized composition biomaterials |
| 12/24/2014 | CN104244984A 用于治疗剂的方法和组合物 A method for therapeutic agents and compositions |
| 12/24/2014 | CN104244969A 含有蛋白酶抑制物的组合物、包含前者的组合物和用于产生和使用前者的方法 Composition containing a protease inhibitor, comprising the former compositions and the generation and use of the former method is used |
| 12/24/2014 | CN104244965A 治疗癌症和其它病症的纳米结构 Treatment of cancer and other disorders nanostructures |
| 12/24/2014 | CN104244960A 皮下组织及皮下脂肪组织增加促进用组合物 Increase in subcutaneous tissue and subcutaneous adipose tissue composition for promoting |
| 12/24/2014 | CN104244954A 具有电偶颗粒的止血材料和装置 Hemostatic material and means having galvanic particulates |
| 12/24/2014 | CN104244946A 新制剂 The new formulation |
| 12/24/2014 | CN104244936A 镇痛剂 Analgesics |
| 12/24/2014 | CN104244931A 经包衣的片剂及其制备 After its preparation coated tablets |
| 12/24/2014 | CN104244930A 口腔崩解片及其制造方法 Orally disintegrating tablets and its manufacturing method |
| 12/24/2014 | CN104244929A 用于调节免疫反应的介孔二氧化硅组合物 Mesoporous silica composition for modulating the immune response |
| 12/24/2014 | CN104244928A 磁性纳米颗粒-SAMiRNA复合物及其制备方法 Magnetic nanoparticles -SAMiRNA compound and preparation method |
| 12/24/2014 | CN104244927A 通过离子凝胶化生产包含双氯酚酸或其一种盐的肠溶海藻酸盐微胶囊的方法以及包含该微胶囊的多颗粒药物组合物 Enteric-alginate gelation by ionic production contains diclofenac or a salt of microcapsules and multiparticulate pharmaceutical compositions comprising the microcapsules |
| 12/24/2014 | CN104244926A 作为强效的hcv 抑制剂的稳定的药物制剂 Stable pharmaceutical formulations as a potent inhibitor of hcv |
| 12/24/2014 | CN104244925A 盐酸氢吗啡酮溶液的提高的稳定性 Stability of hydromorphone hydrochloride solution increased |
| 12/24/2014 | CN104244924A 用于向患者受控给药至少一种活性成分的透皮装置 The transdermal device for the controlled administration to a patient at least one active ingredient |
| 12/24/2014 | CN104244909A 容纳有各自都包含内部液滴和膜的分散体的分散系 Accommodating each dispersion contains a dispersion of droplets and internal membrane |
| 12/24/2014 | CN104244873A 空心药物填充支架和形成该空心药物填充支架的方法 Filling the hollow stent drug method and the formation of hollow filler bracket drug |
| 12/24/2014 | CN104231193A 一种pH与氧化还原双敏感的层交联纳米粒及其制备方法和应用 One pH and redox-sensitive layer of the double cross-linked nanoparticles and its preparation method and application |
| 12/24/2014 | CN104231155A 胆固醇修饰两亲性pH响应刷状共聚物和制备及其胶束 Cholesterol-modified amphiphilic pH response brush copolymer micelles and the preparation and |
| 12/24/2014 | CN104231137A 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法 A polymer-embedded hydrophobic anticancer drugs nanocomposite microspheres prepared |
| 12/24/2014 | CN104230808A 无定形盐酸伊伐布雷定及其制备方法与应用 Ivabradine and its preparation method and application of amorphous hydrochloride |
| 12/24/2014 | CN104230736A 一种抗炎、镇痛的药物及其制剂 An anti-inflammatory and analgesic drugs and their preparations |
| 12/24/2014 | CN104226214A 一种苍术挥发油微胶囊的制备方法及其应用 One kind of Volatile Oil microcapsule preparation method and its application |